207 related articles for article (PubMed ID: 21262846)
41. Cross-talk between the CK2 and AKT signaling pathways in cancer.
Ruzzene M; Bertacchini J; Toker A; Marmiroli S
Adv Biol Regul; 2017 May; 64():1-8. PubMed ID: 28373060
[TBL] [Abstract][Full Text] [Related]
42. Induction and activation of the p53 pathway: a role for the protein kinase CK2?
Meek DW; Cox M
Mol Cell Biochem; 2011 Oct; 356(1-2):133-8. PubMed ID: 21769452
[TBL] [Abstract][Full Text] [Related]
43. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
Schneider CC; Hessenauer A; Montenarh M; Götz C
Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
[TBL] [Abstract][Full Text] [Related]
45. Protein kinase CK2 is inhibited by human nucleolar phosphoprotein p140 in an inositol hexakisphosphate-dependent manner.
Kim YK; Lee KJ; Jeon H; Yu YG
J Biol Chem; 2006 Dec; 281(48):36752-7. PubMed ID: 17038328
[TBL] [Abstract][Full Text] [Related]
46. [Casein kinase 2, the versatile regulator of cell survival].
Volodina IuL; Shtil' AA
Mol Biol (Mosk); 2012; 46(3):423-33. PubMed ID: 22888632
[TBL] [Abstract][Full Text] [Related]
47. Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.
Wang J; Feng C; He Y; Ding W; Sheng J; Arshad M; Zhang X; Li P
Oncotarget; 2015 Sep; 6(29):27700-13. PubMed ID: 26172393
[TBL] [Abstract][Full Text] [Related]
48. Regulation of cancer progression by CK2: an emerging therapeutic target.
Hussain S; Guo Y; Huo Y; Shi J; Hou Y
Med Oncol; 2024 Mar; 41(5):94. PubMed ID: 38526625
[TBL] [Abstract][Full Text] [Related]
49. Protein kinase CK2 impairs spatial memory formation through differential cross talk with PI-3 kinase signaling: activation of Akt and inactivation of SGK1.
Chao CC; Ma YL; Lee EH
J Neurosci; 2007 Jun; 27(23):6243-8. PubMed ID: 17553997
[TBL] [Abstract][Full Text] [Related]
50. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
51. Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
Kim KY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
J Pharmacol Exp Ther; 2004 Jan; 308(1):97-104. PubMed ID: 14569058
[TBL] [Abstract][Full Text] [Related]
52. Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1.
Rao F; Xu J; Fu C; Cha JY; Gadalla MM; Xu R; Barrow JC; Snyder SH
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1773-8. PubMed ID: 25617365
[TBL] [Abstract][Full Text] [Related]
53. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
54. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome.
Uhle S; Medalia O; Waldron R; Dumdey R; Henklein P; Bech-Otschir D; Huang X; Berse M; Sperling J; Schade R; Dubiel W
EMBO J; 2003 Mar; 22(6):1302-12. PubMed ID: 12628923
[TBL] [Abstract][Full Text] [Related]
55. Inositol pyrophosphates promote MYC polyubiquitination by FBW7 to regulate cell survival.
Lolla P; Shah A; Unnikannan CP; Oddi V; Bhandari R
Biochem J; 2021 Apr; 478(8):1647-1661. PubMed ID: 33821962
[TBL] [Abstract][Full Text] [Related]
56. Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation.
Cobb LJ; Mehta H; Cohen P
Mol Endocrinol; 2009 Oct; 23(10):1624-33. PubMed ID: 19556345
[TBL] [Abstract][Full Text] [Related]
57. Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin-proteasome pathway.
Chen H; Chen F; Liu N; Wang X; Gou S
Bioorg Chem; 2018 Dec; 81():536-544. PubMed ID: 30245235
[TBL] [Abstract][Full Text] [Related]
58. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
59. PPIP5K1 Suppresses Etoposide-triggered Apoptosis.
Machkalyan G; Hèbert TE; Miller GJ
J Mol Signal; 2016 Nov; 11():4. PubMed ID: 31051014
[TBL] [Abstract][Full Text] [Related]
60. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
